References: 1. Plus Suture Cost Analysis. 2019. Ethicon, Inc. 2. de Lissovoy G, Pan F, Patkar A, et al. Surgical Site Infection Incidence and Burden Assessment Using Multi-institutional Real-world Data.
Poster presented at International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 14th Annual European Congress; November 5-8, 2011; Madrid, Spain. 3. de Jonge SW, Atema JJ,
Solomkin JS, Boermeester MA. Meta-analysis and trial sequential analysis of triclosan-coated sutures for the prevention of surgical site infection. Brit J Surg. 2017;ePub-DOI: 10.1002/bjs.10445. 4.
World Health Organization. Global guidelines for the prevention of surgical site infection. Accessed November 14, 2022 at https://apps.who.int/iris/bitstream/handle/10665/277399/9789241550475-
eng.pdf?sequence=1&isAllowed=y 5. National Institute for Health and Care Excellence (NICE). Plus Sutures for preventing surgical site infection. Medical technologies guidance. June 28, 2021.
Accessed on November 11, 2022 at https://www.nice.org.uk/guidance/mtg59/resources/plus-sutures-forpreventing-surgical-site-infection-pdf-64372124642245 6. Berrios-Torres SI, Umscheid
CA, Bratzler DW, et al. Centers for disease control and prevention guideline for the prevention of surgical site infection, 2017. JAMA Surg. 2017;152(8):784-791. 7. Ban KA, Minei JP, Laronga C, et al.
American college of surgeons and surgical infection society: surgical site infection guidelines, 2016 update. J Am Coll Surg. 2017;224(1):59-74.
Reduce the Patient Risk and Costs
1-2*
of Surgical Site Infections
by standardizing to Ethicon Plus Antibacterial Sutures.
TM
Smart System
Learn More
Learn More
Triclosan-coated sutures have been
recommended by CDC, WHO, ACS, and NICE.
4-7
The AITA
™
Smart System is a comprehensive solution that
optimizes the way hospitals manage sutures. It turns supplies into
data, data into insights, and insights into better OR
efficiencies.
We call this Intelligent Management.
But don't take our word for it:
Ethicon Plus Antibacterial Sutures
31
randomized
controlled trials
Reduction in
SSI Risk
3†‡
28
%
20
meta
analyses
More than
patients
14,000
For demonstration purposes only.
Sample data.
